Siemen Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.90 Cr
as on 12-12-2024
- Company Age 26 Year, 2 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 15.37 Cr
as on 12-12-2024
- Satisfied Charges ₹ 4.30 Cr
as on 12-12-2024
- Revenue %
(FY 2017)
- Profit 95.20%
(FY 2017)
- Ebitda 99.90%
(FY 2017)
- Net Worth -0.72%
(FY 2017)
- Total Assets 0.18%
(FY 2017)
About Siemen Laboratories (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 1.90 Cr.
The company currently has active open charges totaling ₹15.37 Cr. The company has closed loans amounting to ₹4.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijay and Satish Batra serve as directors at the Company.
- CIN/LLPIN
U24232DL1998PTC096673
- Company No.
096673
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 1998
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Siemen Laboratories (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay  | Director | 07-Jan-2016 | Current |
| Satish Batra | Director | 07-Jan-2016 | Current |
Financial Performance of Siemen Laboratories (India).
Siemen Laboratories (India) Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 95.2% increase in profit. The company's net worth dipped by a decrease of 0.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siemen Laboratories (India)?
In 2017, Siemen Laboratories (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Ltd. Creation Date: 11 Apr 2011 | ₹1.50 Cr | Open |
Karnataka Bank Limited Creation Date: 07 Oct 2010 | ₹1.00 Cr | Open |
Karnataka Bank Limited Creation Date: 25 Jun 2010 | ₹0.45 M | Open |
How Many Employees Work at Siemen Laboratories (India)?
Siemen Laboratories (India) has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siemen Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siemen Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
